Uncertainty and hope in relation to anxiety and depression in advanced lung cancer.

Cancer Ethics Lung Psychological care Quality of life Supportive care

Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
13 Sep 2022
Historique:
received: 24 07 2022
accepted: 31 08 2022
entrez: 13 9 2022
pubmed: 14 9 2022
medline: 14 9 2022
Statut: aheadofprint

Résumé

Intolerance of uncertainty (IU) has been linked to greater psychological distress, whereas hope appears to act as a protective factor against in patients with cancer. The aim of this study is to analyse the modifying effect of uncertainty in the presence of anxiety and depression in patients with advanced lung cancer. Multicentre, prospective, observational, cross-sectional study of 145 individuals with advanced lung cancer. Participants completed the following questionnaires: IU Scale, Hert Hope Index, Brief Symptom Inventory. Among patients with advanced lung cancer, anxiety and depression were prevalent, 30% and 35%, respectively. Uncertainty and hope with respect to their illness negatively affected their psychological distress. Hope and uncertainty accounted for 22% of the variance in anxiety and 34% of depressive symptoms. The hypothesised modifying effects (uncertainty×hope) was not supported in the depressive and anxious symptom models. Our findings indicate that hope and uncertainty are important considerations in understanding mental health in people diagnosed with advanced lung cancer. Identifying patients who lack the resources needed to manage uncertainty and hope in relation to their disease could inform psychosocial intervention provision to improve quality of life.

Identifiants

pubmed: 36100428
pii: spcare-2022-003882
doi: 10.1136/spcare-2022-003882
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Patricia Cruz-Castellanos (P)

Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.

Mireia Gil-Raga (M)

Department of Medical Oncology, Consorci Hospital General Universitari de Valencia, Valencia, Spain.

Paula Jiménez-Fonseca (P)

Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain.

Ismael Ghanem (I)

Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.

Raquel Hernández (R)

Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain.

Nuria Piera-Molons (N)

Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain.

Juana M Cano (JM)

Department of Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.

Alejandro Gallego-Martinez (A)

Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.

Esmeralda Garcia-Torralba (E)

Department of Medical Oncology, Hospital General Universitario Morales Meseguer, Murcia, Spain.

Caterina Calderon (C)

Department of Clinical Psychology and Psychobiology. Faculty of Psychology, University of Barcelona, Barcelona, Spain ccalderon@ub.edu.

Classifications MeSH